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Retrospective analysis of 26 cases of inverted nasal papillomas
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Inverted papilloma (IP) comprises 0.5-4% of benign nasal tumors. The importance is shown by 
local aggressiveness, a high recurrence rate and the possibility of malignant transformation. The 
treatment is controversial, but endoscopic approaches tends to be the choice today.
Aim: To describe clinical, epidemiological and treatment of IP cases in a tertiary hospital.
Methods: Retrospective study consisting of chart reviews of 26 patients diagnosed with IP; evaluation 
of tumor location, clinical staging, follow up, tumor recurrence, malignancy, type of surgery and 
postoperative complications.
Results: There were 13 men and 13 women, the mean age was 57.8 years. The mean follow up 
time was 29.4 months; the recurrence rate was 7.6%. There was a preponderance of T3 and T4 
tumors and a 3.8% malignancy rate. All patients underwent surgical treatment, mostly endonasal 
endoscopic surgery.
Conclusion: IP is an uncommon nasal tumor that originates mainly in the lateral nasal wall, but it 
also affects the paranasal sinuses. Advances in endoscopic surgery are gaining room due to lower 
invasiveness and success rates similar to traditional external techniques for completely resecting 
the tumor. There is a lower recurrence rate, and endoscopy a definitive treatment for malignancy 
cases in this study.
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INTRODUCTION
The inverted papilloma is a benign epithelial tumor 
of the nasal mucosa and paranasal sinuses in which epithe-
lium invaginates towards the stroma1. It originates mostly 
on the lateral nasal wall or within the maxillary sinus. It 
affects three males for every female, mostly in the fifth 
and sixth decades of life2. The most common primary sites 
of the inverted papilloma are the lateral nasal wall (89%), 
followed by the maxillary sinus (53.9%), the ethmoidal 
labyrinth (31.6%), the nasal septum (9.9%), the frontal 
sinus (6.5%), and the sphenoid sinus (3.9%)3.
The inverted papilloma comprises about 0.5% to 
4% of primary nasal tumors, and it is clinically significant 
because it is locally aggressive and its recurrence rates 
range from 5% to 30%. This tumor appears to undergo 
malignant transformation into squamous cell carcinoma in 
5% to 15% cases4-8. It may also cause thinning and even 
erosion of underlying bone, and it may extend into the 
orbit or intracranial cavity8.
It is a rare tumor that has been studied in detail in 
the past 70 years since its classical description by Ringertz 
in 19389. The reasons for this are the instigating features 
of this tumor and the many – controversial – treatment 
possibilities. Incomplete resection of this tumor is asso-
ciated with high local recurrence rates; this is matter for 
concern given the possibility of malignant transformation. 
Thus, aggressive therapy according to the extension of this 
tumor is justified5,9.
The advent and development of nasal endoscopic 
surgery, with improved optic angles and magnification 
power, has made it possible to locate the tumor and its 
insertion more precisely. Consequently, it is now pos-
sible to remove this tumor completely by an endonasal 
approach, with comparable recurrence rates to aggressive 
external procedures such as lateral rhinotomy and medial 
maxillectomy5,10.
The purpose of this study was to describe the clini-
cal and epidemiologic aspects and the surgical treatment 
of inverted papilloma cases diagnosed at the Otorhino-
laryngology Unit of the Sao Paulo Public State Servant 
Hospital in the past 14 years.
SERIES AND METHOD
The study was a longitudinal historical cohort 
study – a retrospective clinical study – consisting of data 
gathering from the registries of patients presenting nasal 
or paranasal tumors confirmed by pathology as being 
inverted papillomas, from August 1996 to August 2010.
A standard questionnaire was used for gathering 
data, focusing on gender, age at diagnosis, prior therapy, 
biopsy results before surgery, symptoms reported in the 
first visit, tumor laterality, nasosinusal topography of the 
tumor, clinical staging, surgical treatment, complications 
of surgery, treatment of the complications, recurrences, 
malignancy, and total follow-up time.
Investigation also included a full clinical history, a 
complete general otorhinolaryngological physical exami-
nation, and 3.5 mm flexible fiber nasofibrolaryngoscopy 
to characterize the tumor. Patients lost to follow-up before 
surgery, or patients whose registries had insufficient data 
were excluded from the sample. Computed tomography 
was done in all patients.
Clinical staging was based on Krouse’s11 staging 
system, shown in Chart 1, which is widely used in most 
studies on this disease.
Staging System for Inverted Papilloma
T1
Tumor totally confined to the nasal cavity, without extension 
into the sinuses. The tumor can be localized to one wall or 
region of the nasal cavity, or can be bulky and extensive 
within the nasal cavity, but must not extend into the sinuses 
or into any extranasal compartment. There must be no con-
current malignancy
T2
Tumor involving the ostiomeatal complex, and ethmoid si-
nuses, and/or the medial portion of the maxillary sinus, with 
or without involvement of the nasal cavity. There must be no 
concurrent malignancy
T3
Tumor involving the lateral, inferior, superior, anterior, or pos-
terior walls of the maxillary sinus, the sphenoid sinus, and/
or the frontal sinus, with or without involvement of the medial 
portion of the maxillary sinus, the ethmoid sinuses, or the 
nasalcavity. There must be no concurrent malignancy
T4
All tumors with any extranasal/extrasinus exension to invol-
ve adjacent, contiguous structures such as the orbit, the 
intracranial compartment, or the pterygomaxillary space. All 
tumors associated with malignancy
Chart 1. The Krouse staging system11.
To categorize the treatment, surgery was classified 
as endonasal endoscopic resection with or without sup-
plementary techniques (sublabial maxillary access), the 
external approach (lateral rhinotomy, Linch incision, or 
degloving), and combined approaches.
Recurrences were described as reappearance of 
tumors after being considered absent (by endoscopy and/
or tomography) in nasal fossae and paranasal sinuses. 
Residual lesions were remaining tumor mass after surgery, 
where one or more supplementary treatments were requi-
red with not more than six month intervals.
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The institutional review board approved this study 
no. 0135/10.
RESULTS
The review consisted of 27 registries of patients with 
a diagnosis of inverted papilloma confirmed by pathology. 
One patient was excluded after leaving the hospital unau-
thorized following an incision biopsy for the diagnosis; no 
treatment was given in this case. No patient was excluded 
because of insufficient registry data.
Of 26 cases, 13 were female and 13 were male. The 
mean age at the diagnosis was 57.8 years, ranging from 
38 to 78 years. Four (15.3%) patients had already under-
gone endonasal treatments at other clinics for removing 
nasal polyps, but these procedures were not well defined. 
Fifteen patients (57.6%) had an incision biopsy describing 
the inverted papilloma prior to surgery. The remaining 
patients were operated for nasal polyps, with the diagno-
sis of inverted papilloma being as an incidental finding 
among inflammatory polyps. All incision biopsy results 
were confirmed after removal of the surgical specimen.
The most frequent complaint was nasal block, in 
92.3% of patients. Graph 1 shows this and other com-
plaints. Three patients reported other complaints (others 
in the Graph), namely hypoacusis, proptosis, and facial 
edema.
Endonasal endoscopic resection was performed in 
17 patients (65.4%); a supplementary maxillary sublingual 
approach was done in six of these patients. An external 
approach only was done in five patients (19.2%), and a 
combined approach for tumor removal was used in the 
other four patients (15.4%). There was no relation between 
tumor staging and the type of surgery or between tumor 
recurrence or residual tumor and the type of surgery.
The most common postoperative complication, in 
four patients, was epiphore. One patients developed sinu-
sitis postoperatively and another had transitory dyplopia. 
Epiphore resolved spontaneously in two patients; one 
was treated by endoscopic dacryocystorhinostomy and 
one is about to be treated similarly. Sinusitis resolved by 
antibiotic therapy.
The mean follow-up time was 29.4 months, ranging 
from one to 132 months. The tumor recurred in two pa-
tients (7.6%), respectively 9 and 60 months after surgery; 
both had been staged as T3 before the first procedure. 
Treatment consisted of endonasal endoscopy, which was 
successful. Five patients had residual tumor after the first 
procedure. One of these patients had been staged as T2 
before surgery; this patient refused further surgery and 
is being monitored every two months. Two others had 
been staged as T3, and are waiting for image studies to 
define further procedures. The remaining two, staged as 
T3 and T4, were successfully treated to remove the entire 
tumor, respectively by a sublabial maxillary approach and 
endonasal endoscopic surgery.
Graph 1. Clinical complaints.
The tumor was bilateral in three patients (11.5%), 
on the left in 10 patients (38.5%), and on the right in 13 
patients (50%). The tumor affected the lateral wall in 88.5% 
of patients, the maxillary sinus in 53.8% of patients, the 
ethmoid labyrinth in 50% of patients, the sphenoid sinus in 
23% of patients, and the frontal sinus in 11.5% of patients. 
In one case the sphenoid sinus only was involved. The 
rhinopharynx was affected in 23% of cases. Graph 2 shows 
the tumor staging (Krouse). In one patient (4%) the tumor 
degenerated into squamous cell carcinoma.
Graph 2. Clinical tumor staging.
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DISCUSSION
The series at our institution concurred with other 
papers we reviewed in relation to age of onset of disease 
– about the fifth and sixth decades of life; the mean age of 
patients was 57.8 years. This was not the case with gender; 
the male to female ratio was 1:1 in our sample, whereas 
it is 3:1 in the literature.
Incision biopsy was done in 57.6% of patients; it 
confirmed that a diagnosis prior to surgery was useful for 
surgical planning. Data in the literature have reported the 
positive predictive value (87.6%), the negative predictive 
value (94.2%), the sensitivity (78.2%), and the specificity 
(96.2%) of incision biopsy for the diagnosis of inverted 
papilloma12. This same study showed that tomography and 
biopsy together are highly accurate for diagnosing this 
disease. The role of pathology should be emphasized, as a 
diagnosis was made only after surgery in 42.4% of patients. 
A diagnosis of inverted papilloma may be made in up to 
0.92% of cases of extensive bilateral nasal polyposis13. 
The inverted papilloma may also be found in unilateral 
polyps with inflammation in the morphological study14, 
which justifies sending all surgical specimens removed by 
endonasal endoscopic surgery to pathology – a routine 
procedure at our institution.
The lateral wall was the most prevalent tumor site, 
which confirms most previously published reports. A few 
studies have found a higher involvement of the ethmoid 
sinus compared to the maxillary sinus; others have shown 
a higher prevalence in the frontal sinus compared to the 
sphenoid sinus. Our results differ from these reports3,8,15. 
However, because details – especially tomography data 
– were lacking, it is possible that several cases reported 
as being on the lateral wall may in fact have been in the 
ethmoid sinus; this may represent a bias in our study for 
this datum.
Most cases were staged as T3, which justifies sur-
gery combining endonasal and sublabial approaches to 
completely resect maxillary sinus tumors. T4-staged tumors 
were given this classification because in most cases these 
tumors extended to the rhinopharynx, and in one case 
malignancy was present. The choice of surgery in each 
case depended not on the site, but on the extent of tumors 
and the surgeon’s evaluation.
Indications for endoscopic surgery have become 
more frequent, and larger tumors are now successfully 
resected with this technique. In recent years we have in-
dicated the external approaches only in exceptional cases 
– and often combined with endoscopy. The recurrence 
rate and the presence of residual tumors were similar in 
a comparison of external approaches and endoscopy; 
thus, we have safely employed the latter to completely 
resect these tumors. More extensive endoscopic surgery 
is possible, such as endoscopic sphenoid nasalization 
(Soler et al.16), which was adopted in one of our patients 
as a supplementary technique after a residual sphenoid 
tumor was detected.
It is important to note that recurrences have been 
found 60 months after the first treatment. Thus, these 
patients should be monitored to detect recurrences at 
earlier phases, thereby implying in fewer difficulties when 
approaching previously operated sites.
CONCLUSION
The inverted papilloma is a benign nasal neoplasm; 
it is clinically important because of its local aggressive-
ness, high recurrence rate, and possibility of malignant 
transformation.
The clinical data of our series concur with most of 
the data in our review of the literature.
Although there were Krouse’s stage 3 and 4 tumors, 
endoscopic approaches predominated, even for more 
extensive tumors. Thus, each surgeon’s experience is a 
determining factor when choosing the type of surgery for 
these cases.
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